CONTEXT AND OBJECTIVE: Methylphenidate is the most widely used drug for treating attention deficit hyperactivity disorder. However, it has important side effects, such as abdominal pain, insomnia, anorexia and loss of appetite, and also some cases of early severe emphysema after drug abuse have been reported. Our aim was to investigate the development of pulmonary emphysema in rats that were subjected to different doses of methylphenidate. DESIGN AND SETTING: Experimental study carried out at the laboratory of a public university. METHODS: Eighteen male Wistar rats were divided into three groups: control (0.9% saline solution); MP 0.8 (methylphenidate, 0.8 mg/kg); MP 1.2 (methylphenidate, 1.2 mg/kg). After 90 days of daily gavage, the animals were sacrificed and lung tissue samples were prepared for analysis on the mean alveolar diameter (Lm).
INTRODUCTION
Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders of childhood and may be accompanied by hyperactive behavior followed by attention problems. 1 The prevalence of ADHD is estimated to be between 3% and 6.3% among school-age children in different geographical areas, 2 including Brazil, and its prevalence is greater among males. 3 The treatment consists of psychological and/or psychiatric intervention together with prescription of stimulant drugs. The association of these two therapies is clinically effective and relatively inexpensive. 4 Methylphenidate is the most widely used psychostimulant drug for ADHD treatment. 2, 5, 6 It improves attention, concentration and full cognitive function. 7 The most common adverse effects are abdominal pain, insomnia, anorexia and loss of appetite. 8 However, the side effects from longer exposure periods have been insufficiently studied, 9 and there are no conclusive data. Sherman 10 found a syndrome of pulmonary vascular sclerosis among abusive (intravenous) users of methylphenidate, and reported the cases of six patients with early severe emphysema. An experimental study on rats showed that there was a high concentration of methylphenidate in lung tissue after intraperitoneal injection. 11 We hypothesized that chronic use of methylphenidate could be related to early pulmonary emphysema through destruction of the alveolar architecture.
OBJECTIVE
Our aim was to investigate the relationship between methylphenidate and pulmonary emphysema in a rodent model. 
METHODS

This
RESULTS
The Lm was greater in all the methylphenidate-treated animals (MP 0.8 = 47.91 ± 3.13, P < 0.01; MP 1.2 = 46.36 ± 4.39, P < 0.05) than in those of the control group (40.00 ± 3.48) (Figure 1 ).
There was no difference between the MP groups. The Lm analysis is illustrated in Figure 2 , which shows the alveolar destruction in methylphenidate-treated animals.
DISCUSSION
In the present study, we used Lm analysis, the gold-standard method for making histological diagnoses of emphysematous pulmonary disease, and observed that there was notable destruction of pulmonary parenchyma in both of the methylphenidatetreated groups.
Until now, the correlation between methylphenidate and pulmonary emphysema 10 seems not to have aroused any attention within the scientific community. This might be explained by the lack of methodological information about intake and exposure to the drug among users. One group of authors has shown interest in the systemic effects of methylphenidate. 11 They tested 37 μmol/kg of methylphenidate on rats and The mechanism through which emphysematous lesions appear is unclear. In a case presented by Sherman et al., 10 a link between respiratory changes and intravenous injection of talc (magnesium trisilicate), which is present in methylphenidate pills, was suggested. Relevant information such as length of exposure and dose has not been elucidated. Although we did not show that the dose was a determining factor for the changes observed, some studies have tested doses that differed from ours. A double-blind study 12 in which the objective was to evaluate the side effects of different doses of methylphenidate classified the doses of 0.3 mg/kg and 0.5 mg/kg as low and high dose, respectively. In contrast, a meta-analysis by Spencer et al. 13 found that the doses used in adult patients were smaller than those used in children (0.5 mg/kg/day versus 1.0 mg/kg/day, respectively).
Because of the lack of consensus in the literature on the ideal dosage of methylphenidate, and based upon the maximum daily dose (60 mg), 15 we decided to test 0.8 mg/kg/day as a therapeutic dose in rats. Furthermore, we considered that application of 
CONCLUSION
In this study, administration of methylphenidate caused destruction of the alveolar septa in the lung parenchyma in Wistar rats, which was histologically compatible with pulmonary emphysema. 
